Glycated Haemogloin, Fasting Plasma Glucose, Plasminogen Activator Inhibitor Type-1, and Soluble Thrombomodulin Levels in Patients with Type 2 Diabetes Mellitus. NJPS [Internet]. 31 de diciembre de 2021 [citado 16 de mayo de 2026];36(2):159-64. Disponible en: https://ojshostng.com/index.php/njphysiologicalsciences/article/view/1520